Aaron Xin is a senior legal consultant in O’Melveny’s Shanghai office. He has worked in the areas of compliance, investigations, capital markets, private equity, and foreign direct investment transactions across various industries in China.
- Tianhui Biotech in the US$75 million NewCo model investment with Oramed
- eHi Car Services in its US$325 million Regulation S high-yield bond offering due 2027
- Adlai Nortye Ltd. (NASDAQ: ANL) in its approximately US$100 million IPO on the Nasdaq
- A buyer consortium led by Fang Holdings (OTC: SFUNY) in a going private transaction involving China Index Holdings (NASDAQ: CIH) valued at approximately US$92 million
- A buyer consortium in the going private transaction of 111, Inc. (NASDAQ:YI)
- OrbusNeich Medical Group in its US$200 million Series A and A-2 Fundraising Rounds
- Citi Group and Morgan Stanley as representatives of the underwriters in the US$183 million follow-on offering of UP Fintech Holding Limited (Nasdaq: TIGR)
- A buyer consortium led by Yunfeng Capital, TF Capital, GIC and management in connection with the acquisition of Cellular Biomedicine Group in a “going private” transaction valued at approximately US$380 million
- Phoenix Media in its US$80 million acquisition of Publication International Ltd.’s Children’s book business
- Xitogen Technologies, a start-up company engaging in sales of new generation flow cytometers in connection with its sale to Danaher Corporation, a global Fortune 200 company headquartered in Washington, DC
- Shanghai Pudong Science & Technology Investment Co., Ltd., a Shanghai-based state-owned investment management company in connection with its acquisition of 14.9% equity interests in LightPath Technologies, Inc., a US-based Nasdaq-listed leading manufacturer of proprietary optical components
- Shanghai Pudong Science & Technology Investment Co., Ltd. in connection with the Series G financing of VeriSilicon Holdings Co., Ltd., a leading IC design company
- Asieris Medical Technologies Co., Ltd., a start-up new generation anti-cancer drug developer, and its onshore affiliate in connection with their Series B financing
- Founders of a leading Chinese vocational education group, 7 Days Group Holdings Limited, a leading hotel chain company, the independent committee of ShangPharma Corporation, a leading pharmaceutical research outsourcing company, and the independent committee of Feihe International, Inc., a leading infant formula producer in their respective “going-private” transactions
- Christine International Holdings Limited, a leading bakery chain operator, in its HK$400 million IPO
- A leading multi-brand B2C online retailer of fashion apparel in China in its proposed US IPO and a leading developer, manufacturer, and distributor of medical equipment in China in its proposed HK IPO
- eHi Car Services Limited, a leading car rental company, in its US IPO
- One of the largest corporate conglomerates in Japan in its acquisition of a car rental company in China
- The online sales business arm of a Chinese state-owned food processing holding company in connection with its proposed acquisition of a Shanghai-based online seller of high-quality food
- A leading developer, manufacturer, and distributor of medical equipment and a rapidly growing agricultural company in China in their US class action lawsuit and SEC investigation
- A global leader in consumer electronics in its FCPA investigation and other internal anti-corruption investigation
- A leading search engine company in the liquidation of its wholly owned subsidiary in China
- A leading foreign-invested plastic package producer in its condemnation and relocation disputes
Languages
- Mandarin Chinese
- Shanghainese
- English
Education
- Fudan University, LL.B.; LL.M.
- Southern Methodist University, LL.M.
Honors & Awards
- Sohmen Scholarships
- Chiang Chen Scholarships
Professional Activities
Bar Exam
- Passed Chinese Bar Exam